by John Conrad | Jan 27, 2023 | Member News
CHICAGO–(BUSINESS WIRE)–ClostraBio, a biotech company focused on developing novel therapeutic solutions for diseases of the gut, is excited to announce a major breakthrough in targeted metabolite delivery to transform intestinal health. This...
by John Conrad | Jan 12, 2023 | Member News
In the wake of Evozyne’s hiring of a seasoned tech-company executive as CEO, the Chicago-based biotech company announced it’s developed an AI model that it hopes will revolutionize development of new therapeutic proteins, significantly accelerating the...
by John Conrad | Oct 31, 2022 | iBIO in the News
Illinois’ bioscience industry has seen major growth in recent years as government grants and private investors have pumped money into the sector, according to a new report. But a shaky economy and venture-capital slowdown this year will likely hamstring...
by John Conrad | Oct 17, 2022 | iBIO in the News
Amid waning venture-capital activity in Illinois and across the country this year as macroeconomic conditions deter investors from cutting checks to startup companies, health care businesses appear to be attracting the most investor interest. Of the 10 largest VC...
